| Literature DB >> 28470327 |
Abstract
BACKGROUND: Coronary tortuosity (CorT) is a common angiographic finding and may be associated with myocardial ischaemia, even without coronary artery disease. Platelets play a crucial role in inflammatory and thrombotic processes and the physiopathology of cardiovascular disease. Larger platelets are more active enzymatically and have higher thrombotic ability compared to smaller platelets. Plateletcrit (PCT) provides complete information on total platelet mass. We aimed to evaluate the relationship between CorT and PCT in patients with chronic stable angina.Entities:
Mesh:
Year: 2017 PMID: 28470327 PMCID: PMC5885048 DOI: 10.5830/CVJA-2017-023
Source DB: PubMed Journal: Cardiovasc J Afr ISSN: 1015-9657 Impact factor: 1.167
General characteristics of the patients
| Coronary tortuosity | |||
| Age, years | 61.8 ± 6.1 (61) | 52.9 ± 8.1 (51) | < 0.001 |
| Female gender, n (%) | 75 (70.8) | 48 (44.4) | < 0.001 |
| Hypertension, n (%) | 96 (90.6) | 54 (50) | < 0.001 |
| Diabetes mellitus, n (%) | 20 (18.9) | 2 (1.9) | < 0.001 |
| Current smoking, n (%) | 30 (28.3) | 22 (20.4) | 0.176 |
Laboratory and echocardiographic parameters
| Haemoglobin (g/dl) | 13.3 ± 1.5 (13.9) | 14.4 ± 1.2 (14.1) | 0.527 |
| Platelets (103/µl) | 236.5 ± 57.1 (229.0) | 218.5 ± 32.1 (219.0) | 0.009 |
| White blood cells (103/µl) | 6.96 ± 2.12 (6.84) | 7.0 ± 1.3 (6.9) | 0.683 |
| Mean platelet volume (fl) | 10.6 ± 1.4 (10.5) | 9.5 ± 0.65 (9.5) | < 0.001 |
| Neutrophils (103/µl) | 4.35 ± 1.6 (4.1) | 3.97 ± 0.99 (4.39) | 0.408 |
| Lymphocytes (103/µl) | 1.99 ± 1 (1.96) | 2.77 ± 0.58 (2.65) | < 0.001 |
| Neutrophil:lymphocyte Ratio | 2.3 ± 1 (2.06) | 1.47 ± 0.48 (1.45) | < 0.001 |
| Platelet:large-cell ratio | 29.3 ± 6.7 (29) | 23.4 ± 5.1 (23.1) | < 0.001 |
| Platelet:lymphocyte ratio | 1.28 ± 0.5 (1.1) | 0.82 ± 0.23 (0.8) | < 0.001 |
| Plateletcrit (%) | 0.26 ± 0.16 (0.24) | 0.21 ± 0.03 (0.20) | < 0.001 |
| C-reactive protein (mg/dl) | 0.48 ± 0.14 (0.45) | 0.44 ± 0.18 (0.41) | 0.267 |
| Total cholesterol (mg/dl) | 209.9 ± 30.5 (210) | 206.3 ± 31.8 (204) | 0.478 |
| [mmol/l] | [5.44 ± 0.79 (5.44)] | [5.34 ± 0.82 (5.28)] | |
| High-density lipoprotein cholesterol (mg/dl) | 48 ± 13.6 (45) | 43.3 ± 5.9 (43) | 0.075 |
| [mmol/l] | [1.24 ± 0.35 (1.17)] | [1.12 ± 0.15 (1.11)] | |
| Low-density lipoprotein cholesterol (mg/dl) | 139.9 ± 24.7 (148) | 132.7 ± 27.4 (134) | 0.02 |
| [mmol/l] | [3.62 ± 0.64 (3.83)] | [3.44 ± 0.71 (3.47)] | |
| Triglycerides (mg/dl) | 152.4 ± 27.4 (134) | 163.1 ± 48.5 (154.5) | 0.517 |
| [mmol/l] | [1.72 ± 0.31 (1.51)] | [1.84 ± 0.55 (1.75)] | |
| Urea (mg/dl) | 35.0 ± 10.5 (36) | 38.7 ± 5.8 (38) | 0.428 |
| Creatinine (mg/dl) | 0.79 ± 0.18 (0.76) | 0.83 ± 0.12 (0.80) | 0.367 |
| Ejection fraction (%) | 60.4 ± 2.5 (61.1) | 61.6 ± 3.2 (62.4) | 0.751 |
Univariate analysis of predictors for coronary tortuosity
| Age, years | 3.275 (1.943–5.627) | < 0.001 |
| Diabetes mellitus, n (%) | 2.539 (1.675–3.592) | < 0.001 |
| Hypertension, n (%) | 2.856 (1.345–3.863) | < 0.001 |
| Female gender, n (%) | 2.348 (1.857–4.362) | < 0.001 |
| Plateletcrit | 2.896 (1.964–4.857) | < 0.001 |
| Neutrophil:lymphocyte ratio | 1.854 (1.376–2.827) | 0.001 |
Multivariate analysis of predictors for coronary tortuosity
| Predictor variables | OR (95% CI) | p-value |
| Age, years | 1.826 (1.354–2.167) | < 0.001 |
| Hypertension, n (%) | 2.158 (1.462–2.937) | < 0.001 |
| Diabetes mellitus, n (%) | 1.583 (1.362–2.835) | < 0.001 |
| Plateletcrit | 1.634 (1.345–2.724) | < 0.001 |